Search company, investor...
Akili Interactive Labs company logo

Akili Interactive Labs

akiliinteractive.com

Founded Year

2011

Stage

Reverse Merger | IPO

Total Raised

$270.4M

About Akili Interactive Labs

Akili Interactive Labs (NASDAQ: AKLI) is building clinically-validated, cognitive treatments and assessments that are delivered in an action video game interface. It provides treatment and patient monitoring for patients with mental health and neurological conditions. Akili was founded in 2011 and is based in Boston, Massachusetts.

Headquarters Location

125 Broad Street 5th Floor

Boston, Massachusetts, 02110,

United States

Compete with Akili Interactive Labs?

Ensure that your company and products are accurately represented on our platform.

Akili Interactive Labs's Products & Differentiators

    EndeavorRx

    The EndeavorRx app is a digital treatment indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD who have a demonstrated attention issue and should be considered for use as part of a therapeutic program. EndeavorRx is an FDA-cleared medical device and must be prescribed by a healthcare professional. It is not intended as a stand-alone therapeutic, nor is it a substitute for a child’s medication.

Research containing Akili Interactive Labs

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Akili Interactive Labs in 2 CB Insights research briefs, most recently on May 26, 2021.

Expert Collections containing Akili Interactive Labs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Akili Interactive Labs is included in 6 Expert Collections, including Mental Health Tech.

M

Mental Health Tech

1,285 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.

D

Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

M

Medical Devices

12,358 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharma Tech

15,795 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

D

Digital Health

10,348 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

H

Health IT

7,901 items

Akili Interactive Labs Patents

Akili Interactive Labs has filed 28 patents.

The 3 most popular patent topics include:

  • Psychiatric diagnosis
  • Cognitive disorders
  • Neurological disorders
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/18/2020

11/22/2022

Psychiatric diagnosis, Physical exercise, Neurological disorders, Cognitive disorders, Cognitive tests

Grant

Application Date

2/18/2020

Grant Date

11/22/2022

Title

Related Topics

Psychiatric diagnosis, Physical exercise, Neurological disorders, Cognitive disorders, Cognitive tests

Status

Grant

Latest Akili Interactive Labs News

Growth Opportunities in the Digital Medicine Market | Proteus Digital Health, Omada Health, WellDoc

May 10, 2023

| Proteus Digital Health, Omada Health, WellDoc News Provided By Share This Article Digital Medicine Market1 PORTLAND, OR, UNITED STATES, May 11, 2023 / EINPresswire.com / -- Digital Medicine Market - Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Digital Medicine Market. Some of the key players profiled in the study are 2Morrow, Ginger.io, Akili Interactive Labs, Livongo Health, AliveCor, WellDoc, Mocacare, Proteus Digital Health, Voluntis and Omada Health. Click To get FREE SAMPLE PDF (Including Full TOC, Table & Figures): https://www.alliedmarketresearch.com/request-toc-and-sample/1671 Digital medicine is an emerging field that uses technology, such as mobile devices, wearable sensors, and artificial intelligence, to improve patient care and outcomes. It includes a wide range of technologies and approaches, such as digital therapeutics, remote patient monitoring, and personalized medicine. Digital medicine can be used in various ways, such as to monitor patient health in real-time, provide personalized treatment recommendations, and facilitate communication between patients and healthcare providers. It can also be used to improve medication adherence, manage chronic conditions, and prevent disease. One of the key advantages of digital medicine is that it enables healthcare providers to collect and analyze large amounts of data about patient health and behavior, which can be used to develop more effective treatments and improve patient outcomes. Additionally, digital medicine can increase patient engagement and empowerment by providing them with more information about their health and giving them greater control over their own care. Digital Medicine Market: Demand Analysis & Opportunity Outlook 2030 Digital Medicine research study defines market size of various segments & countries by historical years and forecast the values for next 7 years. The report is assembled to comprise qualitative and quantitative elements of Digital Medicine industry including: market share, market size (value and volume 2017-2021, and forecast to 2030) that admires each country concerned in the competitive marketplace. Further, the study also caters and provides in-depth statistics about the crucial elements of Digital Medicine which includes drivers & restraining factors that helps estimate future growth outlook of the market. Marketing Communication and Sales Channel Understanding “marketing effectiveness” on a continual basis, help determine the potential of advertising and marketing communications and allow to use of best practices to utilize untapped audience. In order to make marketers make effective strategies and identify why the target market is not giving attention, we ensure the Study is Segmented with appropriate marketing & sales channels to identify potential market size by value & Volume* (if Applicable). Have Any Query? Ask Our Expert @: https://www.alliedmarketresearch.com/purchase-enquiry/1671 The segments and sub-section of Digital Medicine market is shown below: By Technology: Mobile Health, EMR/EHR, Telehealth, Wireless Health By Application: Diabetes, Mental Health, Heart Disease, Smoking, Drug Non-adherence, Obesity, COPD, Asthma Some of the key players involved in the Market are: 2Morrow, Ginger.io, Akili Interactive Labs, Livongo Health, AliveCor, WellDoc, Mocacare, Proteus Digital Health, Voluntis and Omada Health. Important years considered in the Digital Medicine study: Historical year – 2017-2021; Base year – 2021; Forecast period** – 2022 to 2030 [** unless otherwise stated] If opting for the Global version of Digital Medicine Market; then below country analysis would be included: – North America (USA, Canada and Mexico) – Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe) – Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC) – South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.) – Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA) Key Questions Answered with this Study: 1) What makes Digital Medicine Market feasible for long term investment? 2) How influencing factors driving the demand of Digital Medicine in next few years? 3) Territory that may see steep rise in CAGR & Y-O-Y growth? 4) What geographic region would have better demand for product/services? 5) What opportunity emerging territory would offer to established and new entrants in Digital Medicine market? 6) What strategies of big players help them acquire share in mature market? 7) Know value chain areas where players can create value? 8) What is the impact analysis of various factors in the Global Digital Medicine market growth? 9) Risk side analysis connected with service providers? Introduction about Digital Medicine Market Digital Medicine Market Size (Sales) Market Share by Type (Product Category) Digital Medicine Market by Application/End Users Digital Medicine Sales (Volume) and Market Share Comparison by Applications Global Digital Medicine Sales and Growth Rate (2020-2030) Digital Medicine Competition by Players/Suppliers, Region, Type, and Application Digital Medicine (Volume, Value, and Sales Price) table defined for each geographic region defined. Digital Medicine Players/Suppliers Profiles and Sales Data Key Raw Materials Analysis & Price Trends Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis ……..and view more in complete table of Contents Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/7aec4523f88caa22d6e726598d5e75f1 Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia. Read More Articles: Brazil Dental CAD/CAM Materials & Systems Market Update 2023–2030: https://www.einpresswire.com/article/624912087/dental-cad-cam-materials-systems-market-in-brazil-may-see-a-big-move-3m-dentsply-sirona-carestream-dental Brain Health Supplements Market Update 2023–2030: https://www.einpresswire.com/article/624912588/brain-health-supplements-market-expected-to-reach-us-19-7-billion-by-2030-cagr-9-9-pdf-version David Correa

Akili Interactive Labs Frequently Asked Questions (FAQ)

  • When was Akili Interactive Labs founded?

    Akili Interactive Labs was founded in 2011.

  • Where is Akili Interactive Labs's headquarters?

    Akili Interactive Labs's headquarters is located at 125 Broad Street, Boston.

  • What is Akili Interactive Labs's latest funding round?

    Akili Interactive Labs's latest funding round is Reverse Merger.

  • How much did Akili Interactive Labs raise?

    Akili Interactive Labs raised a total of $270.4M.

  • Who are the investors of Akili Interactive Labs?

    Investors of Akili Interactive Labs include Social Capital Suvretta Holdings, Evidity Health Capital, Jazz Venture Partners, Shionogi, Amgen Ventures and 21 more.

  • Who are Akili Interactive Labs's competitors?

    Competitors of Akili Interactive Labs include Pear Therapeutics, Twill, WonderLab, Floreo, Oui Therapeutics and 9 more.

  • What products does Akili Interactive Labs offer?

    Akili Interactive Labs's products include EndeavorRx.

Compare Akili Interactive Labs to Competitors

Click Therapeutics Logo
Click Therapeutics

Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. It enables change within individuals and can be used independently or in conjunction with biomedical treatments. The company was founded in 2012 and is based in New York, New York.

Arcade Therapeutics Logo
Arcade Therapeutics

Arcade Therapeutics uses neuroscientific research to improve mental health through casual, accessible mobile games. It develops digital therapeutic applications designed to provide universal access to mental wellness. Its application offers a game such as a cognitive training algorithm that uses attention bias modification training to alleviate disruptive habits of attention that cause and sustain anxiety. It was formerly known as Wise Therapeutics. It was founded in 2019 and is based in New York, New York.

Twill Logo
Twill

Twill provides digital therapeutics and care delivery models focused on mental and physical health. It partners with enterprises, pharma companies, and health plans to create new products that help support and manage specific mental and physical conditions. The company was formerly known as Happify Health and Happify. It was founded in 2012 and is based in New York, New York.

Limbix Logo
Limbix

Limbix delivers mental health treatment to young people. It offers digital therapeutic for adolescent depression, enabling doctors to provide digital, evidence-based, therapeutic interventions, behavioral health care, and more. The company was founded in 2016 and is based in San Francisco, California.

Lionrock Logo
Lionrock

Lionrock provides treatment online for alcohol abuse, drug addiction, and other substance use disorders by secure video conference.

Litesprite Logo
Litesprite

Litesprite operates as a game development company. It develops games that combine medical treatment and the engagement of mobile gaming to help patients proactively manage chronic health conditions such as stress, anxiety, and depression. The company was founded in 2013 and is based in Bellevue, Washington.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.